Literature DB >> 20233431

Playing games with a thrombus: a dangerous match. Paradoxical embolism from a huge central venous cathether thrombus: a case report.

Nuno Cardim1, Júlia Toste, Vanessa Carvalho, Igor Nunes, Daniel Ferreira, Vanda Carmelo, Ana S N Oliveira, José Ferro, Sylvie Mariana, Adelaide Almeida, Francisco P Machado, José Roquette.   

Abstract

Thromboembolism is a major cause of death in cancer patients. The association between paraneoplastic hypercoagulability of oncological patients and long-term central venous catheters (CVC) may result in CVC associated thrombosis. Patent Foramen Ovale (PFO), especially when associated with atrial septal aneurysm (ASA) is a risk factor for paradoxical embolism. We report a case of paradoxical embolism with stroke in an oncological patient with a huge CVC thrombus playing "ping-pong" with an hypermobile ASA with a PFO. We review the management of hypercoagulability in oncologic patients and discuss the potential role of routine transthoracic echocardiography before the implantation of long term central venous catheters to identify predisposing conditions to paradoxical embolism and select patients for anticoagulant therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20233431      PMCID: PMC2850880          DOI: 10.1186/1476-7120-8-6

Source DB:  PubMed          Journal:  Cardiovasc Ultrasound        ISSN: 1476-7120            Impact factor:   2.062


  15 in total

1.  Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial.

Authors:  S Schulman; P Lindmarker
Journal:  N Engl J Med       Date:  2000-06-29       Impact factor: 91.245

2.  Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events.

Authors:  S Windecker; A Wahl; T Chatterjee; A Garachemani; F R Eberli; C Seiler; B Meier
Journal:  Circulation       Date:  2000-02-29       Impact factor: 29.690

Review 3.  The complex effects of heparins on cancer progression and metastasis in experimental studies.

Authors:  S M Smorenburg; C J Van Noorden
Journal:  Pharmacol Rev       Date:  2001-03       Impact factor: 25.468

4.  Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  William H Geerts; David Bergqvist; Graham F Pineo; John A Heit; Charles M Samama; Michael R Lassen; Clifford W Colwell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

5.  Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients.

Authors:  Sachin S Goel; E Murat Tuzcu; Mehdi H Shishehbor; Eduardo I de Oliveira; Przemyslaw P Borek; Richard A Krasuski; Leonardo L Rodriguez; Samir R Kapadia
Journal:  Am J Cardiol       Date:  2008-10-30       Impact factor: 2.778

6.  Catheter-related thrombosis: a critical review.

Authors:  Jesús Domingo Acedo Sánchez; Jaime Feliu Batlle; Jorge Barriuso Feijoo
Journal:  Support Cancer Ther       Date:  2007-05-01

7.  Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosis.

Authors:  Z Estrov; M Talpaz; G Mavligit; R Pazdur; D Harris; S M Greenberg; R Kurzrock
Journal:  Am J Med       Date:  1995-06       Impact factor: 4.965

Review 8.  Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation.

Authors:  E A Akl; F F van Doormaal; M Barba; G Kamath; S Y Kim; S Kuipers; S Middeldorp; V Yosuico; H O Dickinson; H J Schünemann
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

Review 9.  The incidence and risk of venous thromboembolism associated with cancer and nonsurgical cancer treatment.

Authors:  Anna Falanga
Journal:  Cancer Invest       Date:  2009-01       Impact factor: 2.176

10.  The incidence of patent foramen ovale in 1,000 consecutive patients. A contrast transesophageal echocardiography study.

Authors:  D C Fisher; E A Fisher; J H Budd; S E Rosen; M E Goldman
Journal:  Chest       Date:  1995-06       Impact factor: 9.410

View more
  2 in total

1.  Paradoxical Thromboembolic Ischemic Stroke Following Tissue Plasminogen Activator Instillation for Clogged Central Venous Dialysis Catheter.

Authors:  Ifeanyi Nwosu; Emeka Ibeson; Sehajpreet Singh; Ranbir Singh; Amit Gulati; Dmitriy Zadushlivy; Yizhak Kupfer; Anna Derman; Britney Clemen; Arjun Basnet; Geraldine Nsofor; Annabel U Ogar
Journal:  Cureus       Date:  2021-12-11

2.  Traversing boundaries: thrombus in transit with paradoxical embolism.

Authors:  Varun Miriyala; Muhammad Umer Awan; Kirmanj Faraj; Bipinpreet Nagra
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-09-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.